Cited by 199Angiogenesis and VEGF in CancerImmune cells in cancerSarcoma Diagnosis and Treatment

Interleukin‐34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment

Open access
Ségaliny, Aude I., Mohamadi, Amel, Dizier, Blandine, Lokajczyk, Anna, Brion, Régis, Lanel, Rachel, Amiaud, Jérôme, Charrier, Céline +2 more·2015·International Journal of Cancer

Abstract

Interleukin‐34 (IL‐34) was recently characterized as the M‐CSF “twin” cytokine, regulating the proliferation/differentiation/survival of myeloid cells. The implication of M‐CSF in oncology was initially suspected by the reduced metastatic dissemination in knock‐out mice, due to angiogenesis impairment. Based on this observation, our work studied the involvement of IL‐34 in the pathogenesis of osteosarcoma. The in vivo effects of IL‐34 were assessed on tissue vasculature and macrophage infiltration in a murine preclinical model based on a paratibial inoculation of human osteosarcoma cells overexpressing or not IL‐34 or M‐CSF.In vitro investigations using endothelial cell precursors and mature HUVEC cells were performed to analyse the involvement of IL‐34 in angiogenesis and myeloid cell adhesion. The data revealed that IL‐34 overexpression was associated with the progression of osteosarcoma (tumor growth, lung metastases) and an increase of neo‐angiogenesis.In vitro analyses demonstrated that IL‐34 stimulated endothelial cell proliferation and vascular cord formation. Pre‐treatment of endothelial cells by chondroitinases/heparinases reduced the formation of vascular tubes and abolished the associated cell signalling. In addition, IL‐34 increased the in vivo recruitment of M2 tumor‐associated macrophages into the tumor tissue. IL‐34 increased in vitro monocyte/CD34+cell adhesion to activated HUVEC monolayers under physiological shear stress conditions. This work also demonstrates that IL‐34 is expressed by osteosarcoma cells, is regulated by TNF‐α, IL‐1β, and contributes to osteosarcoma growth by increasing the neo‐angiogenesis and the recruitment of M2 macrophages. By promoting new vessel formation and extravasation of immune cells, IL‐34 may play a key role in tumor development and inflammatory diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.29376

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Well-established cell lines have facilitated investigation into mechanisms of malignancy and high-throughput screens to identify osteosarcoma vulnerabilities.

    “Well-established cell lines, such as SaOS, MG63, KHOS, MNNG-HOS, U2OS and OS-17, have facilitated investigation into mechanisms of malignancy 206,207 and high-throughput screens to identify osteosarcoma vulnerabilities 92,208 .”

    From Osteosarcoma (2022) · cites this paper as [206]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ségaliny, A. I., Mohamadi, A., Dizier, B., Lokajczyk, A., Brion, R., Lanel, R., Amiaud, J., Charrier, C., Boisson‐Vidal, C., & Heymann, D.
Affiliations
Inserm (FR)
Corresponding author
  • Boisson‐Vidal, Catherine
  • Heymann, Dominique
Venue
International Journal of Cancer
Publisher
Wiley
Published
2014-12-13
Volume
137
Issue
1
Pages
73-85
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W1915719235
Cited by
199
References
57
Citations by year
2026: 7 · 2025: 14 · 2024: 14 · 2023: 23 · 2022: 17 · 2021: 21 · 2020: 27 · 2019: 17 · 2018: 25 · 2017: 12 · 2016: 16 · 2015: 6
FWCI
4.64
Type
journal article
Language
en
Open access
Locations
  • International Journal of Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • HAL (submittedVersion, other-oa)
Funders
  • Ligue Nationale contre le Cancer (Equipe Ligue 2012)
  • Region des Pays de la Loire (CIMATH II)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
Keywords
IL-34, osteosarcoma, tumor angiogenesis, metastasis, M2 tumor-associated macrophages, macrophage recruitment, macrophage colony-stimulating factor, endothelial cell proliferation, TNF-α, IL-1β, tumor growth, lung metastasis
MeSH terms
Animals, Bone Neoplasms, Cells, Cultured, Humans, Interleukins, Lung Neoplasms, Macrophages, Neoplasm Transplantation, Neovascularization, Pathologic, Osteosarcoma, Tumor Necrosis Factor-alpha, Gene Expression Regulation, Neoplastic, Cell Proliferation, Mice, Interleukin-1beta, Human Umbilical Vein Endothelial Cells, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review